This announcement is a separate document:
海思科:关于获得创新药HSK39004吸入混悬液IND申请受理通知书的公告
Haisco Pharmaceutical Group: Notice on Obtaining an IND Application Acceptance Notice for the Innovative Drug HSK39004 Inhalation Suspension
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.